Advertisement

Topics

Finanzinvestor buhlt um Diabetes-Tochter von Johnson & Johnson

08:31 EDT 16 Mar 2018 | FinanzNachrichten

LOS ANGELES/NEW BRUNSWICK (dpa-AFX)- Der US-Konzern Johnson & Johnson hat ein milliardenschweres Angebot für seinen Diabetesspezialisten LifeScan erhalten. Die Beteiligungsgesellschaft Platinum Eq...

Original Article: Finanzinvestor buhlt um Diabetes-Tochter von Johnson & Johnson

NEXT ARTICLE

More From BioPortfolio on "Finanzinvestor buhlt um Diabetes-Tochter von Johnson & Johnson"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...